New blood markers could spot liver damage earlier
NCT ID NCT07359742
First seen Jan 23, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study aims to find better blood tests to detect liver scarring (fibrosis) in people with chronic liver disease. Researchers will compare new biomarkers with standard tests like FibroScan and liver biopsy. The goal is to catch liver damage earlier and more accurately. About 110 adults with various causes of liver disease will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROSIS OF LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UZ Brussel
RECRUITINGBrussels, 1090, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.